Calogero Pagliarello, Carlo Renè Girardelli, Ignazio Stanganelli
{"title":"Eruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists.","authors":"Calogero Pagliarello, Carlo Renè Girardelli, Ignazio Stanganelli","doi":"10.4081/dr.2022.9534","DOIUrl":null,"url":null,"abstract":"<p><p>Because of its higher level of safety compared to its parent medicine, thalidomide, lenalidomide (L) is chosen for the treatment of multiple myeloma. We report a patient who, within a month of using L, developed more than 10 basal cell carcinomas.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":"15 1","pages":"9534"},"PeriodicalIF":1.3000,"publicationDate":"2023-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/f8/dr-15-1-9534.PMC10099294.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/dr.2022.9534","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
Because of its higher level of safety compared to its parent medicine, thalidomide, lenalidomide (L) is chosen for the treatment of multiple myeloma. We report a patient who, within a month of using L, developed more than 10 basal cell carcinomas.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
